Search Page

1

Cite

Share

Advances in Tools to Determine the Glycan-Binding Specificities of Lectins and Antibodies.

Haab BB, Klamer Z. Haab BB, et al. Mol Cell Proteomics. 2020 Feb;19(2):224-232. doi: 10.1074/mcp.R119.001836. Epub 2019 Dec 17. Mol Cell Proteomics. 2020. PMID: 31848260 Free PMC article. Review.

Cite

Share

2

Cite

Share

Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA.

Gao C, Wisniewski L, Liu Y, Staal B, Beddows I, Plenker D, Aldakkak M, Hall J, Barnett D, Gouda MK, Allen P, Drake R, Zureikat A, Huang Y, Evans D, Singhi A, Brand RE, Tuveson DA, Tsai S, Haab BB. Gao C, et al. Clin Cancer Res. 2021 Jan 1;27(1):226-236. doi: 10.1158/1078-0432.CCR-20-2475. Epub 2020 Oct 22. Clin Cancer Res. 2021. PMID: 33093149

Cite

Share

3

Cite

Share

Automated Identification and Quantification of Signals in Multichannel Immunofluorescence Images: The SignalFinder-IF Platform.

Barnett D, Hall J, Haab B. Barnett D, et al. Am J Pathol. 2019 Jul;189(7):1402-1412. doi: 10.1016/j.ajpath.2019.03.011. Epub 2019 Apr 23. Am J Pathol. 2019. PMID: 31026417 Free PMC article.

Cite

Share

4

Cite

Share

The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.

Staal B, Liu Y, Barnett D, Hsueh P, He Z, Gao C, Partyka K, Hurd MW, Singhi AD, Drake RR, Huang Y, Maitra A, Brand RE, Haab BB. Staal B, et al. Clin Cancer Res. 2019 May 1;25(9):2745-2754. doi: 10.1158/1078-0432.CCR-18-3310. Epub 2019 Jan 7. Clin Cancer Res. 2019. PMID: 30617132 Free PMC article.

Cite

Share

5

Cite

Share

Biomarkers and Strategy to Detect Preinvasive and Early Pancreatic Cancer: State of the Field and the Impact of the EDRN.

Liu Y, Kaur S, Huang Y, Fahrmann JF, Rinaudo JA, Hanash SM, Batra SK, Singhi AD, Brand RE, Maitra A, Haab BB. Liu Y, et al. Cancer Epidemiol Biomarkers Prev. 2020 Dec;29(12):2513-2523. doi: 10.1158/1055-9965.EPI-20-0161. Epub 2020 Jun 12. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 32532830 Free article.

Cite

Share

6

Cite

Share

Using lectins in biomarker research: addressing the limitations of sensitivity and availability.

Haab BB. Haab BB. Proteomics Clin Appl. 2012 Aug;6(7-8):346-50. doi: 10.1002/prca.201200014. Proteomics Clin Appl. 2012. PMID: 22927350 Free PMC article. Review.

Cite

Share

7

Cite

Share

Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases.

Yue T, Partyka K, Maupin KA, Hurley M, Andrews P, Kaul K, Moser AJ, Zeh H, Brand RE, Haab BB. Yue T, et al. Proteomics. 2011 Sep;11(18):3665-74. doi: 10.1002/pmic.201000827. Epub 2011 Aug 2. Proteomics. 2011. PMID: 21751362 Free PMC article.

Cite

Share

8

Cite

Share

The detection and discovery of glycan motifs in biological samples using lectins and antibodies: new methods and opportunities.

Tang H, Hsueh P, Kletter D, Bern M, Haab B. Tang H, et al. Adv Cancer Res. 2015;126:167-202. doi: 10.1016/bs.acr.2014.11.003. Epub 2015 Feb 7. Adv Cancer Res. 2015. PMID: 25727148 Free PMC article. Review.

Cite

Share

9

Cite

Share

Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Haab BB, Huang Y, Balasenthil S, Partyka K, Tang H, Anderson M, Allen P, Sasson A, Zeh H, Kaul K, Kletter D, Ge S, Bern M, Kwon R, Blasutig I, Srivastava S, Frazier ML, Sen S, Hollingsworth MA, Rinaudo JA, Killary AM, Brand RE. Haab BB, et al. PLoS One. 2015 Oct 2;10(10):e0139049. doi: 10.1371/journal.pone.0139049. eCollection 2015. PLoS One. 2015. PMID: 26431551 Free PMC article.

Cite

Share

10

Cite

Share

Characterizing Protein Glycosylation through On-Chip Glycan Modification and Probing.

Reatini BS, Ensink E, Liau B, Sinha JY, Powers TW, Partyka K, Bern M, Brand RE, Rudd PM, Kletter D, Drake R, Haab BB. Reatini BS, et al. Anal Chem. 2016 Dec 6;88(23):11584-11592. doi: 10.1021/acs.analchem.6b02998. Epub 2016 Nov 15. Anal Chem. 2016. PMID: 27809484 Free PMC article.

Cite

Share